344 related articles for article (PubMed ID: 20542782)
1. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
van Domburg RT; Daemen J; Morice MC; de Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; van Es GA; Wittebols K; Macours N; Stoll HP; Serruys PW
EuroIntervention; 2010 Apr; 5(8):962-7. PubMed ID: 20542782
[TBL] [Abstract][Full Text] [Related]
2. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
[TBL] [Abstract][Full Text] [Related]
4. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
7. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
9. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
Kim BK; Oh S; Jeon DW; Yang JY; Kim JS; Park S; Choi D; Jang Y; Hong BK; Kwon HM; Lee SW; Goh CW; Kwon K; Ryu SK;
J Interv Cardiol; 2009 Oct; 22(5):411-9. PubMed ID: 19702679
[TBL] [Abstract][Full Text] [Related]
12. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
13. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
14. Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study.
Garg S; Sarno G; Gutiérrez-Chico JL; Garcia-Garcia HM; Gomez-Lara J; Serruys PW;
EuroIntervention; 2011 Apr; 6(9):1060-7. PubMed ID: 21518677
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of patients with sirolimus-eluting stents for treatment of bare-metal in-stent restenosis.
Le Feuvre C; Healy-Brucker A; Helft G; Monségu J; Varenne O; Spaulding C; Collet JP; Beygui F; Barthélémy O; Choussat R; Montalescot G; Metzger JP
Int J Cardiol; 2010 Apr; 140(2):219-25. PubMed ID: 19049847
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of overlapping bare-metal stents with sirolimus-eluting stents for long lesions in small coronary vessels.
Kronsteiner E; Lee RW; Sweeney JP; Metallo JR; Stoehr JD; Fortuin FD
J Invasive Cardiol; 2010 Feb; 22(2):76-9. PubMed ID: 20124593
[TBL] [Abstract][Full Text] [Related]
20. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]